2.86
price up icon4.76%   0.13
after-market Handel nachbörslich: 2.85 -0.010 -0.35%
loading
Schlusskurs vom Vortag:
$2.73
Offen:
$2.7
24-Stunden-Volumen:
70,862
Relative Volume:
0.05
Marktkapitalisierung:
$20.64M
Einnahmen:
-
Nettoeinkommen (Verlust:
-
KGV:
-3.5457
EPS:
-0.8066
Netto-Cashflow:
-
1W Leistung:
+16.26%
1M Leistung:
+12.60%
6M Leistung:
+0.35%
1J Leistung:
-7.14%
1-Tages-Spanne:
Value
$2.65
$2.92
1-Wochen-Bereich:
Value
$2.37
$2.92
52-Wochen-Spanne:
Value
$1.33
$6.20

Neuraxis Inc Stock (NRXS) Company Profile

Name
Firmenname
Neuraxis Inc
Name
Telefon
(812) 689-0791
Name
Adresse
11550 North Meridian Street, Suite 325, Carmel
Name
Mitarbeiter
17
Name
Twitter
Name
Nächster Verdiensttermin
Name
Neueste SEC-Einreichungen
Name
NRXS's Discussions on Twitter

Vergleichen Sie NRXS mit anderen Aktien

Aktien Preis Marktkapitalisierung Umsatz Nettogewinn Free Cashflow ENV
Biotechnology icon
NRXS
Neuraxis Inc
2.86 23.44M 0 0 0 0.00
Biotechnology icon
VRTX
Vertex Pharmaceuticals Inc
470.13 119.21B 11.10B -988.90M -1.26B -3.92
Biotechnology icon
REGN
Regeneron Pharmaceuticals Inc
560.93 59.16B 14.09B 4.50B 2.96B 39.28
Biotechnology icon
ALNY
Alnylam Pharmaceuticals Inc
325.28 40.57B 2.35B -269.70M -75.39M -2.09
Biotechnology icon
ARGX
Argen X Se Adr
571.23 34.02B 2.58B 1.06B -1.28B 16.33
Biotechnology icon
ONC
Beone Medicines Ltd Adr
295.59 29.19B 3.81B -644.79M -669.77M -6.24

Neuraxis Inc Aktie (NRXS) Neueste Nachrichten

pulisher
Jul 22, 2025

Is NeurAxis Inc. a good long term investmentSky-high profits - jammulinksnews.com

Jul 22, 2025
pulisher
Jul 22, 2025

What drives NeurAxis Inc. stock priceConsistent high-yield stocks - jammulinksnews.com

Jul 22, 2025
pulisher
Jul 21, 2025

NeurAxis Inc. Stock Analysis and ForecastAccelerated profit realization - jammulinksnews.com

Jul 21, 2025
pulisher
Jul 20, 2025

What analysts say about NeurAxis Inc. stockFast-track wealth growth - jammulinksnews.com

Jul 20, 2025
pulisher
Jul 18, 2025

is neuraxis inc. stock a growth or value play2x 3x 5x Pick Alert - Newser

Jul 18, 2025
pulisher
Jul 18, 2025

Why NeurAxis Inc. stock is on top investor watchlistsMinimized Risk Maximum Return - Newser

Jul 18, 2025
pulisher
Jul 18, 2025

Is NeurAxis Inc. stock a growth or value playFree Signals Group - Newser

Jul 18, 2025
pulisher
Jul 18, 2025

Published on: 2025-07-18 00:27:06 - Newser

Jul 18, 2025
pulisher
Jul 16, 2025

How NeurAxis Inc. stock performs during market volatilityLow Risk Stock Strategies - Newser

Jul 16, 2025
pulisher
Jul 15, 2025

Why NeurAxis Inc. stock attracts strong analyst attentionGrowth Optimized Stock Radar - Newser

Jul 15, 2025
pulisher
Jul 15, 2025

What makes NeurAxis Inc. stock price move sharplySteady Profit Stock Forecasts - Newser

Jul 15, 2025
pulisher
Jul 04, 2025

Thursday’s Insider Moves: Top Executives Make Strategic Trades - Investing.com Australia

Jul 04, 2025
pulisher
Jul 03, 2025

Major Shareholder Sells Massive Stake in NeurAxis, Inc. - TipRanks

Jul 03, 2025
pulisher
Jul 03, 2025

Neuraxis ends Masimo license agreement and launches employee stock plan - Investing.com

Jul 03, 2025
pulisher
Jul 03, 2025

Neuraxis Inc: Brian Hannasch buys $800k in shares - Investing.com

Jul 03, 2025
pulisher
Jul 03, 2025

Neuraxis Inc: Brian Hannasch buys $800k in shares By Investing.com - Investing.com Nigeria

Jul 03, 2025
pulisher
Jun 27, 2025

The Zacks Analyst Blog Highlights Microsoft, NVIDIA, Bank of America, BK Technologies and NeurAxis - Yahoo Finance

Jun 27, 2025
pulisher
Jun 26, 2025

Top Stock Reports for Microsoft, NVIDIA & Bank of America - TradingView

Jun 26, 2025
pulisher
Jun 17, 2025

Neuraxis announces new medical policy with two health insurers - TipRanks

Jun 17, 2025
pulisher
Jun 17, 2025

NeurAxis Announces New Medical Policy Coverage with Two Health Insurers, Adding 700,000 Covered Lives - GlobeNewswire

Jun 17, 2025
pulisher
Jun 17, 2025

NeurAxis, Inc. Expands Insurance Coverage for IB-Stim Therapy, Enhancing Access for Patients with Abdominal Pain - Nasdaq

Jun 17, 2025
pulisher
Jun 17, 2025

NeurAxis (NASDAQ:NRXS) Now Covered by Analysts at Craig Hallum - Defense World

Jun 17, 2025
pulisher
Jun 16, 2025

Neuraxis (NRXS) Initiated with Buy Rating by Craig-Hallum | NRXS Stock News - GuruFocus

Jun 16, 2025
pulisher
Jun 16, 2025

Craig-Hallum initiates NeurAxis stock with buy rating on pediatric device - Investing.com India

Jun 16, 2025
pulisher
Jun 16, 2025

Craig-Hallum bullish on Neuraxis, initiates with a Buy - TipRanks

Jun 16, 2025
pulisher
Jun 10, 2025

Neuraxis, Inc. Secures Key Academic Society Guidelines Recommendation for Treatment of Functional Abdominal Pain in Ibs - MarketScreener

Jun 10, 2025
pulisher
Jun 10, 2025

NeurAxis (NRXS) Gains Momentum with Key Guideline Inclusion | NR - GuruFocus

Jun 10, 2025
pulisher
Jun 10, 2025

Neuraxis secures key academic society guidelines recommendation for FAP - TipRanks

Jun 10, 2025
pulisher
Jun 10, 2025

NeurAxis Achieves Critical Milestone; Secures Key Academic - GlobeNewswire

Jun 10, 2025
pulisher
Jun 10, 2025

Major Medical Guidelines Back NeurAxis $3B IBS Treatment for Children, Only FDA-Cleared Option - Stock Titan

Jun 10, 2025
pulisher
Jun 10, 2025

47,094 Shares in NeurAxis, Inc. (NASDAQ:NRXS) Bought by Citadel Advisors LLC - Defense World

Jun 10, 2025

Finanzdaten der Neuraxis Inc-Aktie (NRXS)

Es liegen keine Finanzdaten für Neuraxis Inc (NRXS) vor. Überprüfen Sie andere Aktien für weitere Informationen.

Umsatz

loading

Nettogewinn

loading

Free Cashflow

loading

ENV

loading
$21.80
price up icon 0.51%
$36.10
price up icon 1.26%
$102.92
price up icon 0.14%
$26.54
price up icon 0.76%
$111.44
price up icon 2.32%
biotechnology ONC
$295.59
price up icon 1.25%
Kapitalisierung:     |  Volumen (24h):